ARTES - Biosimilar Producing Cell Lines and Processes
ARTES offers a range of biosimilar producing cell lines and processes for out-licensing and technology transfer. The listed cell lines are based on yeast, E. coli or mammalian expression system.
Details
- Interferon alpha2a : marketed in Mena region; new technology with improved yield; RCB, USP, DSP IPC/QC protocols available; PEGylated process available
- Interferon alpha2b : licensed to India; RCB, USP, DSP IPC/QC protocols available; PEGylated process available
- Hirudin : marketed in Mena region; new technology with improved yield available, MCB/WCB, USP, DSP, IPC/QC protocols available
- Bivalirudin : licensed to Egypt; RCB, USP, DSP IPC/QC protocols available
- Full length 1 : factor VIII : mammalian; MCB/WCB, USP, DSP IPC/QC protocols available
- Insulin : cell line and process as marketed in India; RCB, USP, DSP IPC/QC protocols available
- Detemir : RCB, USP protocols available; IPC/QC & DSP development time: approx. 6 months
- Liraglutide : RCB, USP protocols available; IPC/QC & DSP development time: approx. 6 months
- Lispro : proof-of-concept for expression achieved; cell line & process to be developed; development time: approx. 9 months
- Glargin : proof-of-concept for expression achieved; cell line & process to be developed; development time: approx. 9 months
- Teduglutide : cell line & process to be developed; development time: approx. 9 months
- As part : cell line & process to be developed; development time: approx. 9 months
- G-CSF : E. coli; RCB, USP protocols available; IPC/QC & DSP development time: approx. 6 months
- hGrowth Hormone : RCB, USP protocols available, IPC/QC & DSP development time: approx. 6 months
- PTH : MCB/WCB, USP; DSP IPC/QC protocols available
- Follicle stimulating Hormone : mammalian; MCB/WCB, USP, DSP IPC/QC protocols available
- Staphylokinase : RCB, USP, DSP IPC/QC protocols available
- HSA : RCB, USP protocols available; IPC/QC & DSP development time: approx. 6 months
Customer reviews
No reviews were found for ARTES - Biosimilar Producing Cell Lines and Processes. Be the first to review!